Neurostimulation, AI for Drug Discovery, X-ray technology + Orthopaedics and more. All covered in my Monday deals summary from the worlds of Medtech and Biotech.
đź”” Helmed by Sanofi veteran, Bionyra emerges with $165m and three licensed I&I assets
🔔In another biotech born out of China’s “NewCo” model, cAMPfield Therapeutics has launched with a $180m series A and a focus on oral medicines for inflammatory diseases.
đź””Milan-based medtech operator Wise closes $34.8m Series D to support neurostimulation technology.
đź””Gero raised $17 million in new financing to advance its AI-driven drug discovery platform focused on aging and chronic disease.
đź””Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
đź””Stockport-based Silveray has raised ÂŁ5m to accelerate production of its next-generation X-ray technology and expand into the healthcare market.
đź””Icarus Medical, a Charlottesville-based med-tech company focused on advancing orthopedic bracing technology raises $7.2m in an over-subscribed Series A funding round.
đź””Houdini Bio, a University of Cambridge spinout emerging from stealth with a novel approach to improving the performance of gene and cell therapies, has raised nearly ÂŁ1.5m.
đź””Private equity firm Altaris scoops up AI drug development outfit Simulations Plus for $375m
đź””Insillico Medicine and SK Biopharmaceuticals have teamed up on an AI-enabled search for drug candidates targeting neuroimmune disorders.
🔔Finnish biotech Aplagon has raised €4.8m to broaden Phase II development of its lead candidate APAC, a first-in-class antiplatelet and anticoagulant therapy for thrombo-inflammatory diseases
đź””BioArctic AB has signed a research and collaboration agreement with Eli Lilly potentially worth $1bn, researching a new treatment combining BioArctic’s proprietary BrainTransporter technology
🔔Dublin’s Jazz Pharmaceuticals has inked a cancer research collaboration potentially worth more than $4bn plus royalties with AbCellera
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.